Application of matrix-metalloproteinases (MMP) inhibitors such as chlorhexidine (CHX) is capable of reducing bond strength loss over time by preventing collagen fibrils degradation. The dentin collagen network is exposed after acid primer etching in etch-and-rinse and self-etching adhesive systems. The incomplete resin infiltration to the bottom of the hybrid layer leads to incomplete collagen encapsulation [1,12,13]. This non-infiltrated collagen is susceptible to proteolytic degradation by collagenolytic host-derived enzymes, such as matrix metalloproteinases (MMPs) [14]. MMPs are a group of zinc-and calcium-dependent enzymes produced by odontoblasts and are trapped within mineralized dentin This in-vitro study compared the effect of 0.2% CHX application on micro-tensile bond strength (micro-TBS) of Single Bond Universal (SBU) and Optibond Solo Plus (OSP) versus Peak Universal Bond (PUB) to dentin after one week and six months. Materials and Methods: Thirty extracted premolars were divided into five groups and their buccal surfaces reduced to expose a flat surface. The groups were: 1. PUB; 2. SBU with CHX application; 3. SBU without CHX application; 4. OSP with CHX application; 5. OSP without CHX application. After etching, the adhesives were applied to the dentin. In groups 3 and 5, CHX was applied for 60 seconds after etching and prior to adhesive application. A resin composite (Z-250) was placed incrementally on the treated dentin. The specimens were sectioned and four slices were obtained per tooth. The slices were placed in distilled water at 37±1 °C for one week and assigned into two subgroups; the first subgroups (control) were immediately tested for bond strength using a universal testing machine, and the second ones (experimental) were tested after six months. Data were analyzed using parametric tests (P value<0.05). Results: The micro-TBS of PUB declined slightly but there was no significant decline over time (p=0.087); while, regardless of the treatment applied to the dentin, the micro-TBS of other groups were significantly decreased after six months (p<0.05). There was no significant difference between PUB and SBU with CHX pretreatment and OSP with and without CHX pretreatment in both storage times (p>0.05). Conclusion: A reduction of the micro-TBS of PUB was not significant after aging but it had no additional bond strength than the other groups. Also, application of 0.2% CHX does not prevent the loss of micro-TBS of SBU and OSP.
For many years, amalgam was the preferred repair material; however, because of worries about aesthetics, mercury toxicity, and the development of lichenoid diseases, its use has decreased. The oral mucosa has a reaction known as the oral lichenoid lesion (OLL). Dental materials, particularly amalgam, medications, and graft-versus-host disease (GVHD), are among the backgrounds of OLL. When restorative materials, most frequently amalgam, come into close touch with the mucosa in hypersensitive people, OLL to dental materials might result. The aim of this review paper is to introduce different aspects of OLL, especially amalgam restorations. The oral mucosa may experience type IV hypersensitivity responses to amalgam and, or its constituents. The clinical appearance, absence of migrations, and direct connection with the afflicted mucosa with the amalgam restorations are often used to confirm the diagnosis. In this regard, dental professionals should considered the OLL incidence around amalgam restorations. In most cases, OLL may be resolved by replacing amalgam restorations with non-metallic restorations. Therefore, a helpful prognostic marker is a topographic link between OLL and amalgam restoration.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.